These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23663134)

  • 21. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scleroderma renal crisis in a patient with anticentromere antibody-positive limited cutaneous systemic sclerosis.
    Sugimoto T; Soumura M; Danno K; Kaji K; Kondo M; Hirata K; Nakazawa J; Uzu T; Nishio Y; Kashiwagi A
    Mod Rheumatol; 2006; 16(5):309-11. PubMed ID: 17039313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From Thibierge-Weissenbach syndrome (1910) to anti-centromere antibodies (1980). Clinical and biological features of scleroderma].
    Meyer O
    Ann Med Interne (Paris); 1999 Jan; 150(1):47-52. PubMed ID: 10093661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis.
    Hamaguchi Y; Fujimoto M; Hasegawa M; Matsushita T; Takehara K
    J Am Acad Dermatol; 2010 Jan; 62(1):142-144. PubMed ID: 19733937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
    García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
    Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
    Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
    Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation.
    Yamanishi Y; Maeda H; Katayama S; Ishioka S; Yamakido M
    J Rheumatol; 1996 Nov; 23(11):1991-4. PubMed ID: 8923381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
    Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
    Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
    Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
    Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases.
    Schild-Poulter C; Su A; Shih A; Kelly OP; Fritzler MJ; Goldstein R; Haché RJ
    Rheumatology (Oxford); 2008 Feb; 47(2):165-71. PubMed ID: 18208821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of cDNA clones encoding the 80-kd subunit protein of the human autoantigen Ku (p70/p80) by antisera raised against ciliary processes of human eye donors.
    Hong TJ; Escribano J; Coca-Prados M
    Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4023-30. PubMed ID: 7960584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six cases positive for anti-centromere antibodies with ulcer and gangrene in the extremities.
    Takahashi M; Okada J; Kondo H
    Br J Rheumatol; 1997 Aug; 36(8):889-93. PubMed ID: 9291859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Digital ulcers in a cohort of 333 scleroderma patients].
    Tiso F; Favaro M; Ciprian L; Cardarelli S; Rizzo M; Tonello M; Ruffatti A; Cozzi F
    Reumatismo; 2007; 59(3):215-20. PubMed ID: 17898881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features of 405 Japanese patients with systemic sclerosis.
    Hashimoto A; Endo H; Kondo H; Hirohata S
    Mod Rheumatol; 2012 Apr; 22(2):272-9. PubMed ID: 21874591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
    Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
    Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.